Asia Credit:Reliance vs.Bharti

    来源: 德意志银行 作者:Harsh Agarwal

    摘要: Earningskickoff.RelianceandBhartihavekickedofftheMarchquarterearningsseasonforIndiancorporatesundero

      Earnings kick off.

      Reliance and Bharti have kicked off the March quarter earnings season forIndian corporates under our coverage. We discuss their results in more detaillater, but numbers broadly look strong on the operational side, albeit leveragehas increased a bit. As for the bonds, we are currently neutral on both, givenvaluations and are waiting for a better entry point. Fundamentally, they remainsolid credits. Relative to each other, Bharti is currently trading roughly 20-25bpwider than Reliance, at the tighter end of historical range (Figure 2). WithRJIO's launch estimated in June (per our equity colleagues), we prefer Relianceover Bharti at this stage, just between the two names. This is also givenReliance's bigger size, lower net leverage and higher rating, which more thanoffset the cyclical nature of its business for us.

      Reliance bonds.

      Reliance bonds are almost back to early Aug'15 levels (pre-RMB devaluation)and just 20-25bp from all time tights. They are amongst the tightest trading inIndia IG (Figure 1), and rightly so, given highest credit rating in the space.

      Having said this, we think the upside is limited from here. Their YTDperformance is also broadly in line with other Asian refining & petrochemicalnames (Figure 5). Hence, maintain Hold. On the curve, we see the 2022s and2040s as more attractive. Since the start of the year, short end is slightly wider,belly is marginally tighter and long end is materially wider (Figure 3). Keyupside risks include deleveraging post the ongoing capex cycle, RJIO'ssuccess, etc., while downside risks are cyclicality of refining andpetrochemicals business, and higher than expected capex spend on RJIO.

      Bharti bonds.

      Contrary to Reliance, Bharti is amongst the widest trading credits (Figure 1).

      While this is not justified fundamentally, weaker underlying corporates areSOEs and benefit from that status. Bharti also suffers from the overhang ofRJIO's impending launch and potential participation in upcoming spectrumauctions. Having said this, its bonds have staged an impressive rally from thewides this year, tightening by approx. 100bp from the lows in Feb, though theyare still around 30-40bp wide from all time tights. Separately, they haveperformed largely in line with regional comps (Figure 6). Maintain Hold.

      Bharti's curve has steepened a bit (Figure 4) and comparatively the 2024sappear the cheapest. Key downside risks are price war post RJIO, aggressivebidding in upcoming spectrum auctions and new supply, while upside risks arefurther asset sales, commitment to maintaining IG ratings, etc.

      India IG strategy.

      As highlighted in our last Asia Credit Monthly, we started the year with apreference for corporates over banks and private sector over SOEs. Whilecorporates have broadly performed in line with banks, privates haveoutperformed SOEs within corporates. We now have a bias towards thelaggard SOEs. We have also turned neutral overall on Indian IG corps as mostof the underperformance has been recouped, and with the RBI rate cut behindus for now, there are a few event risks on the horizon - possible increase insupply, state elections, expiry of RBI governor's term, etc. We do acknowledgethat some positive headlines could come from the passage of bankruptcy codein the ongoing Parliament session and better monsoon than the past couple ofyears.

      

    关键词:

    etc,25,Figure1,Havingsaidthis,Earningskickoff

    审核:yj194 编辑:yj127

    免责声明:

    1:凡本网注明“来源:***”的作品,均是转载自其他平台,本网赢家财富网 www.yjcf360.com 转载文章为个人学习、研究或者欣赏传播信息之目的,并不意味着赞同其观点或其内容的真实性已得到证实。全部作品仅代表作者本人的观点,不代表本网站赢家财富网的观点、看法及立场,文责作者自负。如因作品内容、版权和其他问题请与本站管理员联系,请在30日内进行,我们收到通知后会在3个工作日内及时进行处理。

    2:本网站刊载的各类文章、广告、访问者在本网站发表的观点,以链接形式推荐的其他网站内容,仅为提供更多信息供用户参考使用或为学习交流的方便(本网有权删除)。所提供的数据仅供参考,使用者务请核实,风险自负。

    版权属于赢家财富网,转载请注明出处
    查看更多
    • 内参
    • 股票
    • 赢家观点
    • 娱乐
    • 原创

    监管力度不减 两家私募被罚

    近期,上海两家私募受到监管处罚,分别为上海晟泰智锐资产管理有限公司(以下简称上海晟泰)和弘坤资产管理(上海)有限公司(以下简称弘坤资产),其中上海晟泰被撤销了管理人...

    锂电池个股异动 欧克科技触及涨停

    今日走势:欧克科技(001223)今日触及涨停板,该股近一年涨停1次。异动原因揭秘:1、公司上市日期为2022-12-12,主营为生活用纸智能装备的研发、生产、销售与服务。

    三因素支撑上证指数四连阳

    1月5日,A股三大股指集体高开高走,上证指数涨超1%实现四连阳,北向资金单日净买入127.53亿元,创2022年11月14日以来新高,市场投资意愿有所回暖。对此,分析人士普遍认...

    沃森生物:公司在研发过程中始终与CDE保持紧密沟通,相关临床数据均及时提交监管…

    沃森生物(300142)01月04日在投资者关系平台上答复了投资者关心的问题。投资者:请问13价肺炎疫苗和23价肺炎疫苗目前产能利用情况。若市场需求放大,13价肺炎疫苗和23价肺...

    早知道:2023年1月5号热点概念与题前瞻

    沪指震荡走高以阳线收盘 ,但时空工具信号显示指数当前处于下跌趋势中,波段继续以看空为主。指数近日完成下跌结构后,随即展开上攻,在近期大势分析中多次,结构底部30...

    早知道:2023年1月4号热点概念与题前瞻

    沪指探底回升以阳线收盘 ,但时空工具信号显示指数当前处于下跌趋势中,波段继续以看空为主。指数近期完成老子十二宫下跌结构,此信号往往预示着短线或波段下跌能量出现...

    中国评级下调股票,评级下调的股票以及下调的原因是什么?

    下调评级是指当卖方分析师对一只股票趋势前景的判断变为负面。即新的目标价明显低于之前的目标价时,给予客户的投资建议发生的变化。主要原因是这些上市公司的股票被高估...

    胶原蛋白什么时候吃好你清楚吗?胶原蛋白使用的时候一定要注意这些

    胶原蛋白什么时候吃好你清楚吗?睡觉之前口服效果最好。每晚睡前服用0.5g 到2.6g(约每汤匙0.5g)。晚上睡觉前(10点左右),皮肤处于最旺盛的时候。可以很好的修复皮肤。